Targeted FGFR inhibition results in a durable remission in an FGFR1-driven myeloid neoplasm with eosinophilia

Treatment of the myeloid/lymphoid neoplasm with FGFR1 rearrangement with FGFR1 inhibitor

(2018) S Verstovsek et al.   ANNALS OF ONCOLOGY

Hematopoietic neoplasms with 9p24/JAK2 rearrangement: a multicenter study

(2018) Guilin Tang et al.   MODERN PATHOLOGY

Myeloid/lymphoid neoplasms with FGFR1 rearrangement

(2017) Paolo Strati et al.   LEUKEMIA & LYMPHOMA

Blood and Bone Marrow Evaluation for Eosinophilia

(2016) Daniel F. Boyer   ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE

Myeloid neoplasms with eosinophilia

(2016) Andreas Reiter et al.   BLOOD

The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia

(2016) D. A. Arber et al.   BLOOD

Inhibition of the fibroblast growth factor receptor (FGFR) pathway: the current landscape and barriers to clinical application

(2016) Young Kwang Chae et al.   Oncotarget

Targeting FGFR Signaling in Cancer

(2015) M. Touat et al.   CLINICAL CANCER RESEARCH

Spectrum of Eosinophilic End-Organ Manifestations

(2015) Praveen Akuthota et al.   IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA

Anchored multiplex PCR for targeted next-generation sequencing

(2014) Zongli Zheng et al.   NATURE MEDICINE

Hematologic malignancies with PCM1-JAK2 gene fusion share characteristics with myeloid and lymphoid neoplasms with eosinophilia and abnormalities of PDGFRA, PDGFRB, and FGFR1

(2013) Verena Patterer et al.   ANNALS OF HEMATOLOGY

Myeloid neoplasms associated with eosinophilia and rearrangement ofPDGFRA,PDGFRB, andFGFR1: a review

(2013) N. Savage et al.   International Journal of Laboratory Hematology

AZD4547: An Orally Bioavailable, Potent, and Selective Inhibitor of the Fibroblast Growth Factor Receptor Tyrosine Kinase Family

(2012) P. R. Gavine et al.   CANCER RESEARCH

Ponatinib (AP24534), a Multitargeted Pan-FGFR Inhibitor with Activity in Multiple FGFR-Amplified or Mutated Cancer Models

(2012) J. M. Gozgit et al.   MOLECULAR CANCER THERAPEUTICS

Myeloid and lymphoid neoplasms with eosinophilia and abnormalities of PDGFRA, PDGFRB or FGFR1

(2010) B. J. Bain   HAEMATOLOGICA

8p11 myeloproliferative syndrome: a review

(2010) Courtney C. Jackson et al.   HUMAN PATHOLOGY

Pathogenesis, classification, and therapy of eosinophilia and eosinophil disorders

(2009) Peter Valent   BLOOD REVIEWS